These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18695708)

  • 21. [Acute dopaminergic responsiveness test in diagnosis of Parkinson's disease and Parkinsonian disorders].
    Li W; Feng T; Wang YJ; Lin JX; Xu XT
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2347-9. PubMed ID: 19087697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automated computer differential classification in Parkinsonian Syndromes via pattern analysis on MRI.
    Duchesne S; Rolland Y; Vérin M
    Acad Radiol; 2009 Jan; 16(1):61-70. PubMed ID: 19064213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermal sheet preparations in the evaluation of dermal innervation in Parkinson's disease and multiple system atrophy.
    Novak P; Marya NB; Whren K; Bhawan J
    J Cutan Pathol; 2009 Mar; 36(3):296-301. PubMed ID: 18727665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders].
    Escamilla-Sevilla F; Pérez-Navarro MJ; Muñoz-Pasadas M; Ortega-Léon T; Gallego-Peinado M; Cabello-García D; Gómez Río M; Ortega-Moreno A; Carnero-Pardo C; Rebollo-Aguirre AC; Mínguez-Castellanos A
    Neurologia; 2009 Apr; 24(3):170-6. PubMed ID: 19418293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applause sign in Parkinsonian disorders and Huntington's disease.
    Wu LJ; Sitburana O; Davidson A; Jankovic J
    Mov Disord; 2008 Dec; 23(16):2307-11. PubMed ID: 18972544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iodine-123-meta-iodobenzylguanidine Myocardial Scintigraphy in Isolated Autonomic Failure: Potential Red Flag for Future Multiple System Atrophy.
    Baschieri F; Calandra-Buonaura G; Cecere A; Barletta G; Contin M; Parchi P; Cortelli P
    Front Neurol; 2017; 8():225. PubMed ID: 28603516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of autonomic dysfunction of multiple system atrophy with laryngeal abductor paralysis as an early manifestation.
    Deguchi K; Ikeda K; Shimamura M; Urai Y; Tsukaguchi M; Touge T; Takeuchi H; Sasaki I; Kuriyama S
    Clin Neurol Neurosurg; 2007 Dec; 109(10):892-5. PubMed ID: 17826894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hyposmia in pure autonomic failure.
    Silveira-Moriyama L; Mathias C; Mason L; Best C; Quinn NP; Lees AJ
    Neurology; 2009 May; 72(19):1677-81. PubMed ID: 19433741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proposed neuroimaging criteria for the diagnosis of multiple system atrophy.
    Brooks DJ; Seppi K;
    Mov Disord; 2009 May; 24(7):949-64. PubMed ID: 19306362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple system atrophy.
    Bhidayasiri R; Ling H
    Neurologist; 2008 Jul; 14(4):224-37. PubMed ID: 18617848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Red flags in scleroderma.
    Li Q; Sahhar J; Littlejohn G
    Aust Fam Physician; 2008 Oct; 37(10):831-4. PubMed ID: 19002303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The nursing experience of a patient with parkinsonian type of multiple system atrophy].
    Liao YS; Lin FL
    Hu Li Za Zhi; 2008 Dec; 55(6):93-100. PubMed ID: 19051180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in skin sympathetic involvements between two chronic autonomic disorders: multiple system atrophy and pure autonomic failure.
    Asahina M; Akaogi Y; Yamanaka Y; Koyama Y; Hattori T
    Parkinsonism Relat Disord; 2009 Jun; 15(5):347-50. PubMed ID: 18805037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Effectiveness of [
    Villena-Salinas J; Ortega-Lozano SJ; Amrani-Raissouni T; Agüera E; Caballero-Villarraso J
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Historical overview of REM sleep behavior disorder in relation to its pathophysiology].
    Tachibana N
    Brain Nerve; 2009 May; 61(5):558-68. PubMed ID: 19514516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum cholesterol levels and the risk of multiple system atrophy: a case-control study.
    Lee PH; Lim TS; Shin HW; Yong SW; Nam HS; Sohn YH
    Mov Disord; 2009 Apr; 24(5):752-8. PubMed ID: 19185013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Questionnaire-based assessment of pelvic organ dysfunction in multiple system atrophy.
    Yamamoto T; Sakakibara R; Uchiyama T; Liu Z; Ito T; Awa Y; Yamanishi T; Hattori T
    Mov Disord; 2009 May; 24(7):972-8. PubMed ID: 19243063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anterocollis: clinical features and treatment options.
    Papapetropoulos S; Tuchman A; Sengun C; Russell A; Mitsi G; Singer C
    Med Sci Monit; 2008 Sep; 14(9):CR427-30. PubMed ID: 18758411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Network biomarkers for the diagnosis and treatment of movement disorders.
    Poston KL; Eidelberg D
    Neurobiol Dis; 2009 Aug; 35(2):141-7. PubMed ID: 19013242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.
    Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS
    Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.